|
⚲
|
| Keyboard |
| Apeiron Presight Capital Fund II LP
✚
|
|
|---|---|
| CIK # | 0001840676 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001840676] | |
| 4 | [0001840676] | |
| D | [0001840676] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apeiron Investment Group Ltd | |
| Apeiron Presight Capital Fund II LP | |
| Bionomics Ltd/ADR | |
| Angermayer Christian | |
| Alto Neuroscience Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-04 | Sell | 557 | $0.28 | 156 |
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-03 | Sell | 180,707 | $0.29 | 52,405 |
|
Bionomics Ltd/ADR BNOX
Ordinary Shares
|
2024-10-02 | Sell | 90,806 | $0.33 | 29,966 |
|
Alto Neuroscience Inc ANRO
Series B Preferred Stock · derivative
|
2024-02-06 | Conversion | 416,665 | ||
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 674,658 | ||
|
Alto Neuroscience Inc ANRO
Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 1,063,918 | ||
|
Alto Neuroscience Inc ANRO
Warrants to Purchase Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 444,561 | ||
|
Alto Neuroscience Inc ANRO
Common Stock
|
2024-02-06 | Conversion | 251,881 | ||
|
Alto Neuroscience Inc ANRO
Series A Preferred Stock · derivative
|
2024-02-06 | Conversion | 406,072 |